Immunotherapy Shows Encouraging Results in NeuroblastomaImmunotherapy Shows Encouraging Results in Neuroblastoma
An experimental monoclonal antibody, added to chemotherapy, achieved an 89% response rate in a small early study. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Investigational immunotherapy drug shrinks tumors in high-risk neuroblastoma patients
Investigators report promising preliminary results for an experimental monoclonal antibody when combined with chemotherapy for newly diagnosed neuroblastoma patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 3, 2016 Category: Science Source Type: news
St. Jude Children's Research Hospital research being presented at ASCO Annual Meeting
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital research related to survivorship and the pediatric solid tumors neuroblastoma, adrenocortical carcinoma and nasopharyngeal carcinoma will be presented at the 2016 American Society of Clinical Oncology Annual Meeting. The five-day event begins June 3 in Chicago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2016 Category: Cancer & Oncology Source Type: news
Investigational immunotherapy drug shrinks tumors in high-risk neuroblastoma patients
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital investigators report promising preliminary results at the annual meeting of ASCO for an experimental monoclonal antibody when combined with chemotherapy for newly diagnosed patients. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 3, 2016 Category: Biology Source Type: news
Boy diagnosed with constipation actually has cancer and is fighting for life
Daniel Carter, from Hull, was diagnosed with a huge neuroblastoma - a cancer of the cells that form the nervous system - that had spread from his chest to his spine. (Source: the Mail online | Health)
Source: the Mail online | Health - May 26, 2016 Category: Consumer Health News Source Type: news
Oncurious begins Phase I/IIa study of TB-403 to treat medulloblastoma
Oncurious, along with BioInvent International and Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), has begun a Phase I/IIa study to evaluate the safety, tolerability and preliminary efficacy of TB-403 for the treatment of … (Source: Drug Development Technology)
Source: Drug Development Technology - May 2, 2016 Category: Pharmaceuticals Source Type: news
The effect of explosive blast loading on human neuroblastoma cells - Zander NE, Piehler T, Banton R, Boggs M.
Diagnosis of mild to moderate traumatic brain injury is challenging because brain tissue damage progresses slowly and is not readily detectable by conventional imaging techniques. We have developed a novel in vitro model to study primary blast loading on d... (Source: SafetyLit)
Source: SafetyLit - April 11, 2016 Category: Global & Universal Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
Leah Still Celebrates 1 Year of Being Cancer-Free
Leah was diagnosed with neuroblastoma in 2014. (Source: ABC News: Health)
Source: ABC News: Health - March 25, 2016 Category: Consumer Health News Tags: Health Source Type: news
Mother who was left 'infertile' after battling cancer as a child has TRIPLETS
Jaide Ward, 23, from Wigan, was diagnosed with the life threatening condition neuroblastoma, which affects nerve cells, when she was just four years old. (Source: the Mail online | Health)
Source: the Mail online | Health - March 25, 2016 Category: Consumer Health News Source Type: news
Young neuroblastoma patient and family make new home at Dana-Farber/Boston Children’s
Bridgette West sparkled last fall in the “Fight Song” music video, created by patients at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. But before the 2-year-old became a social media standout with her dancing, she and her family faced challenges that went far beyond a cancer diagnosis.
In the summer of 2015, after struggling for a year with misdiagnosed illnesses, Bridgette and her parents traveled from their Albany, New York, home to Dana-Farber/Boston Children’s. There, tests confirmed she had neuroblastoma, and while Bridgette started treatment, her parents, Roger and Beth, took turns driving...
Source: Thrive, Children's Hospital Boston - March 17, 2016 Category: Pediatrics Authors: Saul Wisnia Tags: Our Patients’ Stories Dana-Farber/Boston Children's Cancer and Blood Disorders Center neuroblastoma Suzanne Shusterman Source Type: news
BioInvent, Oncurious and US research consortium collaborate on TB-403 Phase I/IIa cancer trial
BioInvent International (BINV) and Oncurious have collaborated with the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) to accelerate a Phase I/IIa trial of TB-403. (Source: Drug Development Technology)
Source: Drug Development Technology - March 16, 2016 Category: Pharmaceuticals Source Type: news
VCU scientists work to bring about a new treatment for rare childhood cancer
(Virginia Commonwealth University) Neuroblastoma is a rare cancer that develops in very early forms of nerve cells in the embryo or fetus, and it accounts for the most pediatric deaths for any tumor outside of the brain. The most lethal form of this tumor is often associated with amplification of the gene MYCN, and now VCU scientists may have developed a combination therapy that uses this gene to kill the cancer, instead of making it grow. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 7, 2016 Category: Cancer & Oncology Source Type: news
My Strength To Battle Cancer Came From The Most Unlikely Source
I was fooled by a 7-year-old into thinking that chemotherapy was easy. In 2006, I was fresh out of journalism school and eager to cover whatever my central Missouri newspaper gig threw at me. When my editor assigned me a story on Tim Grant and what would be his final battle with neuroblastoma, I didn't know what to expect. During my first two-hour ride to the hospital to document one of Tim's chemo sessions, I tried to picture chemotherapy. This was a pre-"50/50" world. When I thought "chemo," I imagined Tim in a steel tube or iron lung being bombarded with cancer-fighting radiation -- which also sapped his strength an...
Source: Healthy Living - The Huffington Post - February 3, 2016 Category: Consumer Health News Source Type: news
Leah Wilby was diagnosed with rare neuroblastoma cancer but kept it secret
Leah Wilby, of Great Yarmouth, Norfolk, died from neuroblastoma, rare cancer of nerve cells, at age 16. Her mother said keeping her illness a secret allowed her to live a normal life. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2016 Category: Consumer Health News Source Type: news
[Focus] Beyond static biomarkers—The dynamic response potential of signaling networks as an alternate biomarker?
Properties from simulated pathway dynamics effectively predict neuroblastoma patient outcome. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - December 23, 2015 Category: Science Authors: Jaeyeon Kim and Birgit Schoeberl Source Type: news
